Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics program

1 Mar 2014

Abstract excerpt

Despite a substantial evidence base, implementation of pharmacogenetics into routine patient care has been slow due to a number of non-trivial practical barriers. We implemented a Personalized Anti-platelet Pharmacogenetics Program (PAP3) for cardiac catheterization patients at the University of Maryland Medical Center and the Baltimore Veterans Administration Medical Center Patients' are offered CYP2C19 genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiplatelet Therapy and Cardiovascular Diseases
Share to Pharmacogenetics and Drug Metabolism
Share to Statistical Methods in Clinical Trials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24616408
DOI: 10.1002/ajmg.c.31396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics programPMID 24616408Read ↗

Clinical pharmacogenetics implementation: approaches, successes, and challenges.Semantic proximity Read ↗

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.Semantic proximity Read ↗

Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory.Semantic proximity Read ↗

Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.Semantic proximity Read ↗

Implementation of inpatient models of pharmacogenetics programs.Semantic proximity Read ↗

Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.Semantic proximity Read ↗

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.Semantic proximity Read ↗

Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program.Semantic proximity Read ↗

Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".Semantic proximity Read ↗

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.Semantic proximity Read ↗

Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.Semantic proximity Read ↗

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.